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DNP Project Final Report: Improving Sleep Screening in Patients with Parkinson’s Disease
Abstract
Background: Sleep disturbance (SD) is one of the most common and debilitating non-motor
manifestations of Parkinson’s disease (PD). SD intensifies the disease-related disabilities of
motor and non-motor symptoms. In spite of this, it is often under-recognized and underaddressed by healthcare professionals. The Movement Disorder Society recommends the
Parkinson’s disease Sleep Scale (PDSS – 2) be used to screen and measure severity of overall
sleep problems in this patient population.
Objectives: The purpose of this quality improvement (QI) project is to increase the utilization of
the PDSS-2, a standardized approach to assessment of sleep difficulties. This can facilitate
identification of individual SD to target treatment appropriately. There are two aims: 1) to
improve the screening rate of SD in patients with PD to 80%, and 2), to assess for association
between the screening and treatment planning.
Methods: Using the PDCA study design, the PDSS -2 sleep screening questionnaire were
distributed to every returning patient over three cycles.
Results: We recruited 41 patients. The screening rate improved from 51.2% at the pretest to
82.9% at the posttest, reaching the goal of 80%. The change in the rate of treatment planning
from pretest to posttest is from 52.5% to 31.7 % (p = 0.03). The use of PDSS – 2 did reduced the
rate of treatment planning for sleep.
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Conclusions: This QI project positively increased the rate of sleep screening in at risk patients
with PD. An improvement in the rate of screening and pretest treatment reduced the rate of
treatment planning at the follow up visit.
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Background
Sleep disturbance (SD) is one of the most common and debilitating non-motor
manifestations of Parkinson’s disease (PD) (Endo et al., 2020; Louter, 2012). Sleep disturbance
intensifies the disease-related disabilities of motor and non-motor symptoms (Suzuki, 2021). In
spite of this, it is often under recognized and under addressed by healthcare professionals. The
American Academy of Sleep Medicine recommends using a disease specific, self-administered
questionnaire for the evaluation of insomnia (Sateia, et al., 2017). The Movement Disorder
Society recommends utilizing the Parkinson’s disease Sleep Scale (PDSS-2) to screen and
measure severity of overall sleep problems in this patient population (Högl et al., 2010).
Increased utilization of a standardized approach to assessment of sleep difficulties can facilitate
identification of individual sleep disturbances to target treatment appropriately. Resolution of
sleep disturbances can optimize physical and mental health and greatly enhance the quality of
life of affected patients. This quality improvement project was of interest to both patients with
Parkinson’s disease (PwPD) and the healthcare providers at the Brain Health center.
Problem Description
The current practice regarding screening for SD in the Movement Clinic at the Lou Ruvo
Center for Brain Health varies among individual care providers. An assessment may be part of
the review of systems for new patients, but is inconsistently documented for routine follow up
care. The needs assessment completed before consideration of this process improvement project
revealed that 38 of 56 (68%) patients with PD seen in our clinic had documentation of sleep
assessment in their medical records. The Movement Clinic leadership set a goal to achieve
documentation of SD screening in ≥ 80% of patients with PD seen for new/follow up visits.
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Review of Literature
It is estimated that approximately 930,000 Americans live with Parkinson’s disease and
up to 98% of them experience SD (Melka, et al., 2019). The most common types include
insomnia, rapid eye movement behavior disorder, and restless leg syndrome (Stefanie & Högl,
2020). Symptoms such as depression, pain, fatigue, poorer cognition, and impulse control
behaviors were increased in patients with PD who had sleep problems (Figorilli, et al., 2018).
Sleep dysfunctions were related to a worse quality of life and greater non-motor symptom burden
(Santos-Garcia, et al., 2020). Suzuki (2021) suggested that early detection and management of
sleep-related problems through screening in clinical practice may have a positive impact on the
quality of life of patients with PD.
A systematic literature review was conducted to evaluate evidence in sleep screening for
patients with Parkinson’s disease (Appendix A). In the previous research, the Assessing Care of
Vulnerable Adults project strongly suggested for routine screening of sleep disorders in the older
adults (Martin & Song, 2007). Despite the project data and advocacy, there has been no
development of standard of care in sleep screening procedures (Hughes et al., 2018). In a
randomized clinical trial, more than two-thirds of participants screened positive for at least one
indicator of poor sleep and 38% met criteria for insomnia (Hughes & Martin, 2015). Hughes et
al. (2018) proposed challenges faced in this population in regards to their cognitive and
functional impairments on the impact of sleep disturbances. Full et al. (2019) found that their
higher sleep disturbance scores were strongly correlated with significantly higher pain, stress,
and quality of life scores. Research findings support a strong correlation between sleep
disturbance and adverse outcomes; thus, treatment would positively tip the scale in improving
the quality of life and health outcomes (Martin et al., 2017; Scott et al., 2021; Weaver et al.,

Nguyen 8
2018). Despite the lack of formal recommendation for sleep screening, Mallen et al., 2017 found
that it is feasible to administer point-of-care screening using validated and focused
questionnaires. Validated sleep instruments for screening are vital as there may be discrepancy
between subjective and objective measures of sleep (Hughes et al., 2018). In a non-experimental
trial, 92% of participants underestimated and under-reported their total sleep time (Hughes et
al.,2018). The feasibility of point-of-care screening has been shown to be effective in the
ambulatory care setting, and even recruitment by pharmacists and trained nursing personnel
(Dean et al. 2019, Fuller et al. 2014). Treatment interventions, including cognitive behavioral
therapy, has been shown to improve quality of sleep at a long term follow up (Alessi et al.,
2016). Sleep management begins with routine screening and treatment consideration. The
emphasis in such efforts is to impact the progression of disease and disability, delay or prevent
nursing home placement, and health outcomes (Hughes & Martin, 2017).
Providers recognize the importance of sleep to optimize physical and mental health in
patient care but they may not routinely assess for SD, viewing it as less important than other
aspects of PD management (Grandner & Malhotra, 2015). Additionally, with the majority of this
patient population being 60 years of age or older, many patients interpret SD as a normal part of
the aging process and fail to disclose it to their providers as an area of concern (Luyster, et al.,
2015). Although often overlooked by both clinicians and patients, a thorough evaluation of SD is
of paramount importance and should be mandatory for all providers involved in the care of
patients with PD (Baumann, 2019; Voysey, et al., 2021). Identification of specific SD to
optimize targeted treatments can not only enhance quality of life for these patients and their
families, but may also mitigate disease burden and delay progression (Baumann, 2019; Voysey,
et al., 2021). Treating sleep dysfunctions in patients with PD begins with a comprehensive
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assessment of this aspect of their condition, preferably using objective scales (Voysey, et al.,
2021). The Parkinson’s Disease Sleep Scale, version 2 (PDSS-2) (Trenkwalder, et al., 2011) is
recommended by the Movement Disorder Society Task Force as the preferred screening tool as it
includes a broad range of possible sleep disturbances common in patients with PD (Kurtix, et al.,
2018).
Purpose
The purpose of this Doctor of Nursing Practice Project was to improve the screening rate
for sleep disturbance in PwPD. The study protocol engaged the clinicians and team members to
work collaboratively to disseminate, gather, and document a standardized sleep screening scale,
PDSS – 2 in at-risk patients to increase identification and targeted treatments to optimize patient
care outcomes.
Methodology
Design
This quality improvement (QI) project used a pretest-posttest, same subject design to evaluate the
outcomes. The PLAN-DO-CHECK-ACT (PDCA) model is used to guide the process.

Setting and Population
The setting for the project took place in a Midwestern Brain Health clinic, subspecialized
in neurodegeneration. The population of focus was PwPD.
Interventions
The PDSS – 2 was implemented as a structured sleep dysfunction assessment tool for
PwPD in the Movement Disorder Clinic. It was selected because of the recommendation by The
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Movement Disorder Society, and for its ease of use for patients, and high test-retest reliability,
validity, and precision, as well as its potential to measure treatment effectiveness (Trenkwalder,
et al., 2011; Kurtis, et al., 2018). This is a revised PDSS scale, which includes subscales to
address unmet needs, “motor problems at night,” “PD symptoms at night,” and “disturbed sleep.”
The scale consists of 15 items that are scored from 0 (never) to 4 (very frequent). The total score
range is 0 – 60, where higher scores indicating increased severity of sleep problems. The
diagnostic cut off score is ≥ 15. The scale has a sensitivity of 72.1% and specificity of 72.9%
(Trenkwalder, et al., 2011). The self-administration time is approximately 10 minutes and
reflects on the signs/symptoms within the past week. The score for each item response is marked
on the survey allowing for easy scoring by providers. It is available free for use in clinical
practice and non-funded research (Mapi Research Trust, 2019).
An Epic smart phrase entitled “. SLEEPSCREEN” was built into the electronic medical
record to facilitate provider documentation of review of the PDSS-2 results. The
“.SLEEPSCREEN” smart phrase included two items: “PDSS-2 completed – YES/NO,” and
“Score”. Recommendations regarding management of SD was at the discretion of the provider.
Measures
The outcome measure was the percentage of PwPD with documented screening for SD in
the medical record. This was calculated by dividing the number of patients who have
documentation of SD screening in their medical records by the total number of PwPD seen on
the day of the audit.
Pre-implementation
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As part of the planning (P) phase of the PDCA cycle, the project leader completed a
retrospective chart audit of 56 PwPD who were seen in the Movement Disorders clinic during a
randomly selected work week. Thirty-eight of the 56 patients (68%) had documentation of some
form of sleep assessment completed by the provider. The assessment and treatment plan
reflected discussions of general sleep patterns and the presence/absence of active dream
behaviors. Since the documentation rate fell below the department goal of 80% the project leader
completed a literature review and created an evidence-based plan to increase SD screening
among PwPD seen in the clinic. The project leader met with the director and leadership team and
received support for this quality improvement project.
Implementation
In the Do (D) phase of the PDCA cycle, the project leader implemented the planned
project beginning with orienting the Movement Disorders team (providers, nurses, and medical
assistant staff) to inform them of the project purpose, rationale, and to solicit their engagement in
the process. All team members were oriented to the process for the administration and scoring of
the PDSS-2. The team leader reviewed patients scheduled for the Movement Disorders clinic and
identified those diagnosed with PD prior to the start of clinic each day. She prepared a Patient
Information Sheet (Appendix B) and a PDSS-2 for each identified patient and placed them in
easy access for the medical assistants who placed patients in exam rooms. The medical assistants
were asked to review the Patient Information Sheet with each patient during the routine rooming
in process, provide the volunteer patients with the PDSS-2, and request the patient hand the
completed survey to the provider during the office visit. The medical assistants distributed the
PDSS-2 paper and pencil questionnaires to those who agree to participate.
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Providers were asked to briefly review the questionnaire, total the score, and document
the results in the electronic medical record using the smart phrase “.SLEEPSCREEN.” The
documentation was captured within the office visit progress notes under the Objectives section.
This uniformly captured all the PDSS – 2 screening questionnaires that were completed and the
corresponding scores. Any recommendations based on the questionnaires were at the discretion
of the provider. Once the providers completed the “.SLEEPSCREEN” documentation in the
medical record, they handed them to the nursing team for collection.
During the Check (C) phase, the project leader audited the medical records of all PwPD
seen in the clinic on a randomly selected day in weeks two, four, and six of the project. The
number of patients with documentation of SD assessments were divided by the total number of
patients seen on that day to determine percentage with completed assessments. After each audit
the project leader prepared and present a summary of progress to the Movement Disorder team
using run charts.
In the Act (A) phase of the cycle, the project leader met with the movement staff and
providers to update them on the progress toward the goal of 80%. This was done biweekly at the
team meeting. The results were presented in a run chart. This enhanced staff and provider
engagement with continued screening. Feedback was obtained after each cycle (a total of 3
cycles) on barriers, feasibility, and general recommendations. Using feedback from the team, the
process was repeated. Modifications to improve provider/staff engagement and/or patient
engagement was made based on the progress and team feedback.
Post-implementation
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At the completion of the QI project, the project leader continued to conduct chart audits
bi-monthly for the following six months, then on an as needed basis thereafter. The PDCA cycle
may be repeated as necessary to support sustainability.
Study Aims/Analysis Plan
The study had three primary aims: to improve the screening rate of sleep disturbance in at
risk PwPD, to meet the benchmark goal of a minimum of 80% sleep screening consistently
documented, and to assess whether the PDSS – 2 impacts the treatment planning.
•

To improve the screening rate of sleep disturbance in at risk PwPD, a baseline assessment
of sleep screening documentation was conducted and revealed that 38 of 56 (68%) PwPD
seen in the clinic had documentation of sleep assessment in their medical records. An
assessment may be part of the review of systems for new patients, but is inconsistently
documented for routine follow up care. The intervention was the distribution of the PDSS
– 2 questionnaires, education regarding score, and documentation of the scale. The
posttest data was the collection of completed sleep screening.

•

A benchmark goal of 80% was set by Movement Clinic leadership, reflecting a 12%
increase in documentation: The same sample participants had their previous charts
reviewed for prior documentation of sleep screening, creating the pretest data. The
completed documentation of sleep screening in the same sample participants was the
posttest data.

•

Assessment for an association between the PDSS – 2 questionnaire and treatment
planning: The sleep treatment planning documentation from the pretest and posttest was
assessed for change.

Nguyen 14
Data Analysis
Data for the QI project was collected and entered into an Excel spreadsheet. SPSS was
then used to analyze the data. Controlled charts were utilized to assess for trends and maintain a
visual progress.
Descriptive statistics was used for categorical variables, age, and gender to check for
distribution, data entry errors, and missing data. McNemar test was used to answer the clinical
question, is there a change of screening rate from pretest to posttest? The outcome data were also
compared to the bench mark to assess success.
Alignments of Aims and Outcomes
The first aim to improve the screening rate of sleep disturbance in at risk PwPD was
measured using the change in percentage of patients screened for PD sleep disturbance. The
sleep disturbance is measured by the PDSS – 2. The change in the screening rate was assessed in
two ways. First, the biweekly audits were assessed for a change in percentage of patients
evaluated to determine progress. Secondly, the final percentage of patients screened was
compared to the goal of 80% established by the department leadership to determine goal
achievement.
To evaluate for a change in the rate of treatment planning for sleep pre/post intervention,
we used the percentage of documented treatment planning in the electronic health record post
intervention. An EHR chart review was completed for all PwPD follow ups during the biweekly
audit. The percentage of completed documentation of treatment planning was compared to the
total charts viewed for the same 41 patients. We anticipated that increased screening is correlated
with greater likelihood for identification of SD and targeted therapy.
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The project consisted of three cycles with each lasting a period of two weeks. The
feedback obtained from the team after the first cycle was that the barrier in completing the PDSS
– 2 involving new patients was difficult to determine. Providers found that some patients may be
inappropriately screened if they were presenting first to confirm or rule out a diagnosis of PD or
other movement related disorders. It also affected their consultation time dedicated to patient
interview and diagnostics to derail to discussion of sleep concerns. This was factored into the
change made for cycle 2.
In cycle 2, the project was revised to screen only returning PwPD. The medical assistants
who were responsible for the rooming and distributing the questionnaires were made aware of
the revision. The removal of new patient screening contributed to the lack of total daily charts
available for auditing. This variable was not initially taken into account resulting in a second
revision. The project leader met with the project mentor and clinical site nurse scientist to factor
in the change. The feedback from the panel was to reduce the minimum chart audit to 12.
To summarize, in cycle 2, we reduced the minimum number of charts audited. After the
completion of cycle 2, the team feedback was regarding incomplete questionnaires. Some
patients were unable to complete the questionnaires between the rooming process and the time
the provider begins the appointment. This led to a bit of confusion from both parties as the
patient tries to submit post visit (completion of paperwork in the waiting room) as the chart
would already be completed, or the provider is unable to review the score or provide evaluation
and management for any sleep disturbance. The project leader recommended that the patients
complete the form at home and return at the next follow up meeting. This would provide patient
reinforcement that their health data is valuable. For the incomplete screening, providers were
notified to document in the chart “NO” in the screening portion of the objective assessment.
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In cycle 3, the PDSS – 2 screening was only applied to PwPD returning for follow up
visits. Any incomplete screenings were encouraged to be returned at the next visit. The results
for each cycle were compared to the goal set by the clinic leadership of 80%. The charts with
completed PDSS – 2 continued to trend up after each review toward meeting the final goal.
The outcomes measured all align with increasing sleep disturbance screening in at risk
PwPD and engaging the clinicians and team members in the process of patient care delivery.
Instruments/Tools
The PDSS – 2 is a standardized sleep screening questionnaire. The PDSS – 2 was
assessed for internal and test-retest-reliability. For the internal consistency, Trenkwalder et al.
(2011) computed the Cronbach alpha of 0.73, and for subscales, 0.47 to 0.66. For the test-retestreliability, the questionnaire was repeated after 1 – 3 days and the intra-class-coefficient for the
total score was 0.80, a sufficiently high result (Trenkwalker et al., 2011, p. 648). In regarding to
discriminative validity, there were significant differences found with the PDSS – 2 score with the
Clinical Global Impression Severity Scale (item 1) and Hoehn and Yahr severity. It is available
free for use in clinical practice and non-funded research (Mapi Research Trust, 2019).
Data Accuracy
A biweekly chart audit was completed per cycle, for a total of three cycles. The
following data from the electronic health record was gathered: The participant’s age, gender,
previous screening prior to enrollment (pre-intervention), screening at the enrollment visit (postintervention), previous treatment planning related to sleep (pre-intervention), treatment planning
at the enrollment visit (post-intervention), participant report taking dopamine replacement
therapy (PD medication), and the Unified Parkinson’s disease Rating Scale (UPDRS-III) Motor
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Score. The Objective section was reviewed for documentation of PDSS-2, along with the score,
if available. The intervention was the dissemination, administration, and scoring of PDSS – 2.
To maximize the number of scheduled patients, the audit was done on a day when all
providers were scheduled to be in clinic. A minimum of 12 charts was audited per cycle. To
ensure data accuracy, the project leader reviewed the data entered and verified it with the number
of entries against the daily chart count. The gender and age match were also used for
verification.

Data collection
To collect screening data, the project leader completed biweekly chart audits. The
objective section of the progress notes was reviewed for the pre-conceived EPIC smart phrase
‘Parkinson's Disease Sleep Scale (PDSS-2), PDSS - 2 completed: *YES/NO, Score.’ If the chart
did not contain this documentation, the patient or provider failed to complete the questionnaire
and/or documentation within the chart. If the chart contained the above documentation, with
‘PDSS – 2 completed: NO,’ this indicates the patient declined to complete the questionnaire or
they did not complete in time at the start of the appointment time. To avoid disruption to the
visit, the incomplete questionnaires were documented as ‘NO’ sleep screening were completed.
In the data set, the documentation was indicated as ‘YES’ or ‘NO’.
To evaluate for objective 1, the project leader divided the total number of charts screened
by the total number of PD patients scheduled. In cycle 1, 14 participant charts were evaluated for
the completion of sleep screening. The same participant charts were reviewed one follow up visit
prior, to assess for the presence of prior documentation of sleep screening assessment. The
documentation from the prior assessment became the data for the pretest and the documentation
for the current audit after the implementation of PDSS – 2 questionnaires became the posttest
data. This provided two sets of pretest and posttest data for comparison.
Results
Participant characteristics
Table 3 shows the demographic of the patients. Of the 41 participants, male and female
were about equal (male: 21, 51.8%; female: 20, 48.8%) and the median age group was 71 – 80
years of old. The participants were categorized into five age groups, 5 were within 51 – 60
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(12.2%), 7 were within 61 – 70 (17.1%), 19 were within 71 – 80 (46.3%), 8 were within 81 – 90
(19.5%), and 2 were 91and above (4.9%).
The change in the rate of screening is summarized in table 4. In the pretest, 51.2% of
participants received the sleep screening. Figure 1 is a bar chart demonstration of the data from
table 4. In the posttest, 82.9% received sleep screening. The result is an improvement of 31.7%,
which is not statistically significant, p = 0.14. The screening rate during each cycle is reported in
table 5. Figure 2 is a run chart demonstration of the data summarized in table 5. In cycle one, the
screening rate changed from 50% to 78.6%; in cycle 2, it changed from 53.3% to 80%; while in
cycle 3, it changed from 50% to 91.7%. Overall, the goal of 80% screening rate was met.
For the second aim, the change in the rate of treatment planning from pretest to posttest is
from 52.5% to 31.7 %, the result is shown in table 6. The result is a change of 20.8%, which is
statistically significant, X² = 5.03, p = 0.03. The use of PDSS – 2 did impact the rate of treatment
planning for sleep. The result indicates that if they had received an intervention or treatment
planning related to sleep disturbance in the pretest, then they would be less likely to have a
recurring sleep disturbance in the posttest that require follow up.
Discussion
The project’s successful results were largely due to the team collaboration efforts and
engagement. The implementation of the PDSS – 2 increased awareness of sleep disturbance in
PwPD, its key role in patient care management, and engaged health care providers and patients
to take charge of their health. The improvement in screening and targeted treatments may lead to
improved patient satisfaction of consumer healthcare. Patient satisfaction has an implication on
healthcare policy and value-based reimbursement.
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The future plan to maintain project sustainability is to utilize the results to influence
patient care outcomes through multidisciplinary team collaboration. The goal is to collaborate
with the clinic’s health psychologist to improve on efficiency of intervention for sleep
disturbance. The project leader and the health psychologist have met to detail the plans for
shared medical appointments for PwPD that suffer from sleep disturbance. The finding from this
QI will contribute to the efforts for screening and identifying patients with the greatest needs for
referral. The PDSS – 2 will aid in differentiating behavioral needs that may benefit from
cognitive behavioral therapy rather than required for medical management.
The implication for quality and safety is that the project outcome supports standardized
documentation to improve effective communication between providers and patients. This QI
effort shifts how providers within a clinic communicate to one another of the screening
assessment, plan of care, and serve as an effective tool for longitudinal follow up.
Proper documentation of a standardized sleep screening in PwPD will also enhance
research recruitment. Clinical trials that focus on recruitment of sleep quality, safety, and
intervention can easily connect with potential interested participants.
Conclusion
The results showed that the intervention improved the screening rate by nearly 32% to
reach the pre-set goal of 80% (82.9%). As shown in table 5, there was an improvement in
screening rate each cycle. Providers and staff were more likely to continue with sleep screening
and documentation during the intervention and shortly after. The engagement and excitement
with the QI is likely what was responsible for the positive trend in documentation of sleep
screening. Nonetheless, the results were positive and showed that PDSS – 2 sleep screening
documentation can be implemented seamlessly into the current clinic practice setting. It can
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provide more longitudinal data for patient management and care outcomes. The treatment
planning pre- and post- test data were statistically significant. Providers were less likely to
document and evaluation and management of sleep screening in patients that were previously
screened/treated. The overall goal is to increase awareness of sleep disturbance in patients with
Parkinson’s disease by both healthcare providers, medical assistants, patients, and caregivers. By
increasing awareness through increasing screening with a standardized scale, there overarching
goal is to provided targeted treatments for sleep disturbance and optimizing patient satisfaction
with their health and quality of life.
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Table 1. Data Collection/Evaluation and Analysis Methods Table
Aims/Evaluation

Measures

Questions

Measure

Data

Recruitment

Type

Source

Method/

Timing/Frequency

Calculation/

Goal/

Statistics

Benchmark

80%

Population
Improve sleep screening

% of

rate in patients with

documented

Parkinson’s disease.

sleep

Process

EHR chart

All PD patient follow up

Biweekly for 6- week;

Percentage/

review

visits during the project

once per cycle

Proportion

intervention period

screening
Does the use of a formal

completed

sleep scale, PDSS-2 improve

in the

the rate of screening?

electronic
health
record

Evaluate for the change in

% of

the rate of treatment

documented

planning for sleep.

treatment
plan for
sleep in the

Process

EHR chart

All PD patient follow up

Biweekly for 6- week;

Percentage/propor

review

visits during the project

once per cycle

tion

intervention period

80%
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Does the use of a sleep scale,

electronic

PDSS – 2 improve the rate of

health

treatment planning involving

record

sleep?

Providers are satisfied with

Provider

PDSS – 2 content and

satisfaction

usability.

ratings

How satisfied are providers
with the content and
usability of the scale?

Outcome

Provider

All providers utilizing

Administered once, 2

Mean score

Mean score of 4 or

survey

the scales during the

weeks post-

above (5-point

project period

intervention

scale)
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Table 2. Data Dictionary Table
Data Element

Data Label

Data Type

Definition/Purpose

Data Values &
Coding

Participant number

Part#

Continuous

Participant

Numeric

Enrollment Date

Date

Alpha numeric

Enrollment Date

Alpha-numeric
DD-MMM

Gender

Gender

Text

Self-identified gender
from EHR

Participant Age

Age_Group

Numeric

EHR

Group

Categorical
1, Male; 2, Female
Categorical
51, 51-60;
61, 61- 70;
71, 71-80;
81, 81-90;
91, 91+

PreSleep Screening

PreSlpScr

Text

Chart reviewed: sleep
screening previous

Categorical
1, Y; 2 N

documentation in EHR.
PostSleep Screening

PostSlpScr

Text

PDSS – 2 Questionnaire
completed

Categorical
1, Y; 2 N
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PostScreeScore

Numeric

PDSS – 2 Score

Numeric

PreTrtPln

Text

Chart reviewed:

Categorical

Screening Score
Pre-Treatment

treatment planning

Planning

1, Y; 2, N

documentation
Post-Treatment

PostTrtPln

Text

Chart reviewed:
treatment planning

Planning

Categorical
1, Y; 2, N

documentation
OnOFF

OnOFF

Text

Chart reviewed: Patient
report ON PD

Categorical
1, ON; 2 OFF

medication.
Motor Score

Motor_Score

Numeric

Unified Parkinson’s
disease Rating Scale
(UPDRS III)

Descriptive statistics of age and gender are summarized in table 3.
Table 3. Characteristics of the sample (n=41)
Variable

Number (%)

•

51-60

5 (12.2%)

•

61-70

7 (17.1%)

•

71-80

19 (46.3%)

•

81-90

8 (19.5%)

Numeric
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2 (4.9%)

91

Gender
•

Female

20 (48.8%)

•

Male

21 (51.2%)

Table 4. Pretest sleep screening and posttest sleep screening (n=41)
Yes

No

Pretest

21(51.2%)

20 (46.3%)

Posttest

34 (82.9%)

7 (17.1%)

Statistics

X2=2.14, p=0.14

Figure 1. Bar Chart Demonstrating Pretest and Posttest Sleep Screening Difference

Percentage of Sleep Screening Documentation

Pretest sleep screening and posttest sleep
screening
82.9

51.2

46.3

17.1
PRETEST

POSTTEST
Pretest and Posttest Analysis
Yes

No
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Table 5. Screening rate during each cycle
n

Pretest screening

Posttest screening

Cycle 1

14

7 (50.0%)

11 (78.6%)

Cycle 2

15

8 (53.3%)

12 (80.0%)

Cycle 3

12

6 (50.0%)

11 (91.7%)

Figure 2. Run Chart for PDSA Cycles and Pre/Posttest Results

Percentage of Sleep Screening Documentation

PDSA Cycles and Sleep Screening
Documentation
91.7
78.6

80

50

53.5

50

CYCLE 1

CYCLE 2

CYCLE 3
PDSA Cycles

Pretest screening

Posttest screening

Table 6. Pretest Treatment Planning and Posttest Treatment Planning (n=41)

Pretest Treatment Planning

Yes

No

21 (52.5%)

20 (48.7%)
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Posttest Treatment Planning

13 (31.7%)

Statistics

X²=5.03 p=0.03

28 (68.3%)

Table 7. Control Chart Cycle 1 Chart Audit for PDSS – 2 Sleep Screening Documentation
and Scores

Part#
1
2
3
4
5
6
7
8
9
10
11
12
13
14

Date GenderAge_group
PreSlpScreening
PostSlpscreening
PostScreeScore
PreTrtPln
PostTrtPln
14-Oct
M
51
1
1
17
2
1
14-Oct
M
61
2
1
23
1
1
14-Oct
F
81
1
1
8
1
2
14-Oct
M
61
2
1
11
2
2
14-Oct
M
51
1
1
33
1
1
14-Oct
F
61
2
2
2
2
14-Oct
F
71
2
1
21
2
2
14-Oct
M
81
2
1
11
2
1
14-Oct
M
81
2
1
24
2
2
14-Oct
F
71
1
1
21
1
2
14-Oct
M
71
2
2
2
2
14-Oct
F
51
1
1
49
1
1
14-Oct
F
61
1
1
38
1
1
14-Oct
M
71
1
2
1
2

Note: The control chart was imported from SPSS. The variable label 1 = Yes, 2 = No. The
blanks are missing sleep screening score from incomplete documentation. The age is grouped as
follow: 51, 51 – 60; 61, 61 – 70, 71, 71 – 80, 81, 81 – 90; 90 is 90 and above.
Table 8. Control Chart Cycle 2 Chart Audit for PDSS – 2 Sleep Screening Documentation
and Scores
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15
16
17
18
19
20
21
22
23
24
25
26
27
28
29

28-Oct
28-Oct
28-Oct
28-Oct
28-Oct
28-Oct
28-Oct
28-Oct
28-Oct
28-Oct
28-Oct
28-Oct
28-Oct
28-Oct
28-Oct

F
M
M
F
M
F
M
M
F
M
M
F
F
M
F

35

61
71
71
81
71
51
71
71
71
71
81
71
71
91
71

1
2
1
2
1
1
1
2
1
2
1
1
2
1
2

1
1
1
1
1
1
2
2
1
2
1
1
1
1
1

11
10
36
7
28
8

7
10
12
3
11
10

1
2
1
2
1
1
1
2
1
2
1
1
2
2
2

2
2
1
1
1
1
2
2
2
2
2
2
2
2
2

Note: The control chart was imported from SPSS. The variable label 1 = Yes, 2 = No. The
blanks are missing sleep screening score from incomplete documentation. The age is grouped as
follow: 51, 51 – 60; 61, 61 – 70, 71, 71 – 80, 81, 81 – 90; 90 is 90 and above.
Table 9. Control Chart Cycle 3 Chart Audit for PDSS – 2 Sleep Screening Documentation
and Scores

30
31
32
33
34
35
36
37
38
39
40
41

11-Nov
11-Nov
11-Nov
11-Nov
11-Nov
11-Nov
11-Nov
11-Nov
11-Nov
11-Nov
11-Nov
11-Nov

F
M
M
F
F
M
F
F
F
M
M
F

71
61
81
81
61
71
71
91
71
81
51
71

2
1
2
1
1
1
2
1
1
2
2
2

1
1
1
1
1
1
1
1
1
1
2
1

11
25
12
14
51
18
23
28
15
20
27

2
1
2
1
1
1
2
1
1
2
2
2

2
1
2
1
1
2
2
2
2
2
2
2
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Note: The control chart was imported from SPSS. The variable label 1 = Yes, 2 = No. The
blanks are missing sleep screening score from incomplete documentation. The age is grouped as
follow: 51, 51 – 60; 61, 61 – 70, 71, 71 – 80, 81, 81 – 90; 90 is 90 and above.
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Appendix A
Evidence Table

Article #

Author
& Date

Evidence
Type

Sample,
Sample Size,
Setting

Study
findings that
help answer
the EBP
Question

Observable
Measures

Limitations

Evidence
Level &
Quality

Alessi et
al., 2016

Randomized
Controlled
Trial

Communitydwelling
veterans aged
60 and older
who met
diagnostic
criteria for
insomnia of 3
months
duration or
longer (N =
159).

Intervention
subjects had
greater
improvement
than controls
between the
baseline and
posttreatment
assessments,
the baseline
and 6-month
assessments,
and the
baseline and
12-month
assessments.

Primary
outcomes,
including selfreported (7-day
sleep diary) sleep
onset latency,
wake after sleep
onset, total wake
time, and sleep
efficiency;
Pittsburgh Sleep
Quality Index
(PSQI); and
objective sleep
efficiency (7-day
wrist actigraphy,
were measured at
baseline, at the
posttreatment
assessment, and
at 6- and 12month follow-up.

Predominant
male veteran
population,
findings may
not be
generalized
to the older
women and
nonveterans.

Level I
Evidence:
High
quality

Dean et
al., 2019

Nonresearch/
Quality
Improvement

Twelve
nurses, mean
age 42.6,
100% female,
92%
Caucasian,
83%
baccalaureate
or higher,
average
nursing
experience
was 18 years,
in the
ambulatory
cancer care
setting.

Nurses
reported
100%
satisfaction
and improved
confidence in
stimulation
learning for
identification
of sleep
disorders
using an
online
screening
tool.

Holland Sleep
Disorders
Questionnaire
during tow in situ
stimulations
using
standardized
patients and
debriefing.

Small
sample size,
extensive
nursing
knowledge
may impact
the impact
beliefs and
attitudes
about sleep.

Level V
Evidence:
Good
quality

Full et al.,
2019

Nonexperimental

Older adults
(N = 307)
were recruited
from
retirement
communities
in San Diego,

Higher sleep
disturbance
scores were
significantly
associated
with higher
scores on the

Depression CSD
C-10 Score,
Quality of Life
(PQOL) Score,
Perceived Stress
Score, and
PROMIS Sleep

Selfreported
sleep
measures are
limiting.

Level III
Evidence:
High
quality
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CA, average
83.6 years
(SD 6.4) and
predominately
female
(72.3%).

depression
scale, higher
stress score,
and lower
quality of life.

Disturbance
Scale.

Fuller et
al., 2014

Randomized
Controlled
Trial

325
participants
were recruited
through 23
community
pharmacies,
mean age
55.5 ± 16.7,
46,7% male.

218 (67%)
participants
were at risk of
OSA,
insomnia or
RLS and
these
participants
were referred
to their
primary
physician.

Subjective risk
assessment only
versus using a
questionnaire,
versus risk
assessment +
objective marker
for OSA.

Participant
biased as
they were
exposed to
the
screening
after seeing
the
recruitment
material.

Level I
Evidence:
Good
quality

Hughes &
Martin,
2015

Randomized
Controlled
Trial
(screening
phase of a
larger study)

Sixty – eight
participants
from an Adult
Day Health
Care
(ADHC).
96% male,
4% female,
mean age 79
years old.

More than
two thirds
(n = 48,
70.6%)
reported one
or more
characteristics
of poor sleep,
and 38% of
participants
met basic
criteria for
insomnia.
Individuals
with insomnia
attended
ADHC less
frequently,
reported
worse sleep
quality and
shorter sleep
duration, and
were more
likely to
endorse
trouble falling
asleep,
staying
asleep, and
waking up too
early (p <
0.001).

28-item insomnia
screening tool
using validated
questionnaires
with simplified
response options.

The data
was gathered
based on a
screening
phase of a
larger study.
Medical and
psychiatric
information
was not
visible to the
screener.

Level I
Evidence:
High
quality

Sample may
be biased
since the
participants
were
recruited as
a part of a
VA
program.

DNP PROJECT RESULTS

39

Hughes et
al., 2018

Nonexperimental

Fifty-nine
Adult Day
Health Care
participants
(95% male,
mean age =
78 years)

Disturbed
sleep was
common, yet
there was no
agreement
between
subjective and
objective
sleep
assessment
methods.
Compared
with objective
measures,
one-half of
participants
reported
worse sleep
efficiency
(SE) on
questionnaires
while onequarter overestimated SE.
Participants
reporting
worse pain
had a greater
discrepancy
between
subjective and
objective SE.

Subjective sleep
assessment using
the Pittsburg
Sleep Quality
Index (PSQI)
versus wristactigraphy. The
7-item Insomnia
Severity Index
and
Dysfunctional
Beliefs and
Attitudes Scale
(DBAS).

The length
and
complexity
of the scales
used, PSQI
and ISI may
be
prohibitive
to older
adults with
cognitive
and
functional
impairments.

Level III
Evidence:
High
Quality

Mallen et
al., 2017

Randomized
Controlled
Trial

Patients aged
≥45 years old
with
osteoarthritis
attending a
primary care
clinic, mean
age 65, 57%
female, 98%
white
race/ethnicity,
sample size
was 2,042
patients.

Study found
that it is
feasible to
incorporate
point-of-care
screening of
anxiety
(GAD-2) and
depression
(PHQ-2) in
the electronic
medical
record.
Primary
outcome,
yield higher
pain scores at
follow up;
secondary
outcome,
anxiety and
depression
did not reduce

Depression
symptoms (PHQ2) at

Anxiety was
screened in
addition to
depression.
Included
only patients
with
osteoarthritis
in the
primary care
setting
which may
not be
applicable to
the general
population.

Level I
Evidence;
high quality

3 months:
Standardized
Mean Difference
(SMD) 0.14 (0.01
to 0.26)
6 months: SMD
0.22 (0.09 to
0.35)
12 months: SMD
0.10 (0.03 to
0.23)
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following
intervention.

Martin et
al., 2017

Randomized
Controlled
Trial

Forty-two
individuals
(mean age: 77
years, 93%
male)
enrolled in a
VA ADHC
program.

A short
behavioral
sleep
intervention
program
showed
improvement
on sleep
efficiency,
number of
night time
awakenings,
and minutes
awake at
night
compared to
information
only
controlled.

In-person sleep
and health
assessments at
baseline, post
treatment, and 4
month follow up,
3 days of wrist
actigraphy,
Pittsburgh Sleep
Quality Index
(PSQI), and the
insomnia severity
index.

Participants
were not
able to be
screened for
sleepdisordered
breathing
despite
evidence of
higher
prevalence
in the older
adults.

Level I
Evidence:
High
quality

Scott et
al., 2021

Metaanalysis of
randomized
controlled
trials

Sixty-five
trials
comprising 72
interventions
and N = 8608
participants
were included

Improvement
of sleep can
lead to
significant
effect on
composite
mental health,
depression,
anxiety, and
rumination, as
well as stress
and psychosis
symptoms.

Self-reported
measures of
global sleep
quality, the
Pittsburg Sleep
Quality Index
(PSQI), outcomes
specific to a
given sleep
disorder that
assess sleep
continuity and
impact on daily
life, and
individual
components of
reported sleep
quality.

Few studies
reported
impact for
long term,
those that
did report
longer
follow up
had smaller
effects.

Level II
Evidence:
Good
quality

Weaver et
al., 2018

Quasiexperimental

A sample of
416 shift
workers at
four hospitals
participated,
mean age is
33.2, 87.8%
female, 11%
male. fulltime (80.8%)
nursing staff
(64.7%), 95%
of the sample
reported

Of the 416
hospital
workers who
participated,
two in five
(40.9%)
screened
positive for a
sleep disorder
and 21.6%
screened
positive for
depression or
anxiety.

88% of those
who screened
positive for a
sleep disorder
were previously
undiagnosed and
untreated.

Treatment
data were
not
collected, or
follow up in
reduction of
symptoms.

Level II
Evidence:
Good
quality

(Prospective
cohort study)

Nearly onequarter of the
study sample
(n = 96, 23.1%)
reported
excessive
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predominant
clinical role.

screening
positive for a
sleep disorder
was
associated
with 83%
increased
incidence of
adverse safety
outcomes.
Screening
positive for
depression or
anxiety
increased the
risk by 63%.

daytime
sleepiness (>10
on the Epworth
Sleepiness
Scale); seventy
participants
(16.8%) had
previously been
diagnosed with a
sleep disorder
and 6.0%
(n = 25) were
receiving
treatment for a
sleep disorder at
study baseline.
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Appendix B
Parkinson’s disease Sleep Scale – 2
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Appendix C
Patient Information Sheet

Sleep Screening in Patients with Parkinson’s Disease
Quality Improvement Project Information Sheet
This is a quality improvement project, with the aim to increase provider’s sleep screening
in patients with Parkinson’s disease using a standardized tool. The Parkinson’s Disease Sleep Scale
– 2 is an objective tool developed to measure the severity of sleep problems, specific to this patient
population. The scale is presented in a questionnaire format. There are 15 questions total and will
take approximately 10 minutes to complete. The completion of the scale will be part of your preappointment visit and not take time from your visit with the provider. Your participation is
voluntary and there is no compensation. The score will be calculated by the provider and entered
into your visit notes.
Thank you for your cooperation,
Jenny Nguyen, MSN, FNP – C

